Fig. 8.
Fig. 8. Apoptosis of CD34+ cells from MDS-BM. CD34+ cells were isolated from the BM of patients with MDS (CMMoL, A and D; RA, B and E) and a healthy donor (C, F ). Cells were then treated and analyzed as described in the legend to Fig 7. The population of viable cells (R1) after treatment was 39%, 51%, and 8% in the patients (D, E) and the healthy control (F ), respectively. (A, B, and C) Cells before treatment. A second experiment with cells from three other patients with MDS and three healthy donors gave similar results.

Apoptosis of CD34+ cells from MDS-BM. CD34+ cells were isolated from the BM of patients with MDS (CMMoL, A and D; RA, B and E) and a healthy donor (C, F ). Cells were then treated and analyzed as described in the legend to Fig 7. The population of viable cells (R1) after treatment was 39%, 51%, and 8% in the patients (D, E) and the healthy control (F ), respectively. (A, B, and C) Cells before treatment. A second experiment with cells from three other patients with MDS and three healthy donors gave similar results.

Close Modal

or Create an Account

Close Modal
Close Modal